This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Björklund, N. K.
Right arrow Articles by Greenberg, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Björklund, N. K.
Right arrow Articles by Greenberg, C. R.
Related Collections
Right arrow Other neurology
Right arrow Health education
Right arrow Other nutrition & metabolism
Right arrow Maternal-fetal medicine
CMAJ • October 31, 2000; 163 (9)
© 2000 Canadian Medical Association or its licensors

Letters
Correspondance

Folic acid supplementation: more work is needed

Natalie K. Björklund, Jane A. Evans and Cheryl R. Greenberg

Department of Biochemistry and Medical Genetics; Departments of Biochemistry and Medical Genetics, Pediatrics and Child Health, and Community Health Sciences; Departments of Biochemistry and Medical Genetics, and Pediatrics and Child Health University of Manitoba Winnipeg, Man.

James House and colleagues recently reported that 25% of Newfoundland women had low or indeterminate red blood cell folate levels (< 420 nmol/L) at their first prenatal visit.1 Booth and colleagues reported that the reference values in use today were defined on the basis of absence of biochemical signs of folate deficiency.2 These values do not reflect recommendations for folic acid intake to prevent neural tube defects.3 Booth and colleagues found that for women of child-bearing age attempting to reach a folate intake of 400 µg/day, deficiency is best defined as a serum homocysteine value above 10 µmol/L or a red blood cell folate value below 615 nmol/L.2

We recently completed a case–control study of 28 women with a previous pregnancy resulting in a neural tube defect and 38 matched controls with a normal pregnancy outcome. All mothers were ascertained to be screen positive by an elevated maternal serum {alpha}-fetoprotein level between 1983 and 1999. We used a semiquantitative food frequency survey to measure dietary and supplemental intake of folate and vitamins B12 and B6. The dietary survey was later validated using biochemical results from 25 and 32 of the case and control mothers respectively. Linear regression analysis showed significant correlation between reported intake of folate and serum folate (p = 0.018) and red blood cell folate levels (p = 0.002), but an inverse correlation with serum homocysteine levels (p = 0.029). Analysis indicated consistent underreporting of actual vitamin intake (common in food frequency surveys). We found no difference between case and control subjects in terms of intake or eating patterns.

Even after correcting for underreporting, we found that in our case and control groups combined, 58% of women were not consuming enough folate, 46% were not consuming enough vitamin B6 and 28% were not consuming enough vitamin B12. Only 12% reported preconceptional supplementation whereas 82% reported supplementing after they became pregnant. There was no difference in preconceptional supplementation patterns after 1994, when preconceptional supplementation with folic acid was recommended.4

Although none of our mothers were folate deficient according to current reference values, 34% had serum homocysteine values in excess of 10 µmol/L and 10% had levels higher than 13 µmol/L, the current reference value. Our results, albeit in a much smaller and differently selected group, support the results of the Newfoundland study and indicate that vitamin B6 intake may also be suboptimal in many women of child-bearing age.

References

  1. House JD, March SB, Ratnam S, Ives E, Brosnan JT, Friel JK. Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit. CMAJ 2000;162(11):1557-9.[Medline]
  2. Booth CK, Clark T, Fenn A. Folic acid, riboflavin, thiamine, and vitamin B-6 status in a group of first time blood donors.Am J Clin Nutr 1998;68(5):1075-80.[Abstract]
  3. Hall JG. Folic acid: the opportunity that still exists. CMAJ 2000;162(11):1571-2.[Medline]
  4. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. CMAJ 1994;151(2):159-66.[Abstract]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Björklund, N. K.
Right arrow Articles by Greenberg, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Björklund, N. K.
Right arrow Articles by Greenberg, C. R.
Related Collections
Right arrow Other neurology
Right arrow Health education
Right arrow Other nutrition & metabolism
Right arrow Maternal-fetal medicine